A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults.

@article{Mejia2019AMO,
  title={A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults.},
  author={Sonia Blanco Mejia and Mark Messina and Siying S. Li and Effie Viguiliouk and Laura Chiavaroli and Tauseef Ahmed Khan and Korbua Srichaikul and Arash Mirrahimi and John L Sievenpiper and Penny M Kris-Etherton and David J A Jenkins},
  journal={The Journal of nutrition},
  year={2019},
  volume={149 6},
  pages={
          968-981
        }
}
BACKGROUND Certain plant foods (nuts and soy protein) and food components (viscous fibers and plant sterols) have been permitted by the FDA to carry a heart health claim based on their cholesterol-lowering ability. The FDA is currently considering revoking the heart health claim for soy protein due to a perceived lack of consistent LDL cholesterol reduction in randomized controlled trials. OBJECTIVE We performed a meta-analysis of the 46 controlled trials on which the FDA will base its… CONTINUE READING
BETA